{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:29:59Z","timestamp":1783488599645,"version":"3.55.0"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T00:00:00Z","timestamp":1644537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Many studies have demonstrated the positive clinical value of progestin-primed ovarian stimulation (PPOS) in patients with polycystic ovary syndrome (PCOS) who underwent assisted reproductive technology. However, the underlying factors contributing to this phenomenon remain unclear. We conducted a retrospective observational study to compare the clinical outcomes of women with PCOS who underwent PPOS or the short protocol to identify possible factors that influence the outcome.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This study included 304 patients who underwent PPOS and 152 patients who underwent short protocol from April 2014 to July 2019 after propensity-score matching. Human menopausal gonadotropin (hMG) dose, hormone profile, embryo development, and clinical outcomes of frozen-thawed embryo transfer (FET) cycles were compared. The primary outcome measure was the implantation rate. Logistic regression was performed to identify contributing factors, and receiver operating characteristic curve analysis was used to calculate the cutoff of luteinizing hormone (LH) difference ratio in clinical outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Compared with the short protocol, PPOS resulted in a higher implantation rate (43.4% vs. 31.9%, <jats:italic>P<\/jats:italic> &amp;lt; 0.05), clinical pregnancy rate (61.8% vs. 47.4%, <jats:italic>P<\/jats:italic> &amp;lt; 0.05), and live birth rate (48.4% vs. 36.8%, <jats:italic>P<\/jats:italic> &amp;lt; 0.05). Similar fertilization, cleavage, and valid embryo rate per oocyte retrieved between groups were observed. The LH difference ratio was positively associated with implantation rate [<jats:italic>P<\/jats:italic> = 0.027, odds ratio (OR) = 1.861, 95% CI: 1.074\u20133.226]. The relationship between the LH difference ratio with clinical outcomes was confirmed by receiver operating characteristic curve analysis and comparisons among patients grouped by the LH difference ratio.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The implantation rate was associated with the LH difference ratio during ovary stimulation in patients with PCOS. Our results provide the explanation why PPOS shows the positive clinical outcomes for patients with PCOS.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphys.2021.744968","type":"journal-article","created":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T09:17:18Z","timestamp":1644571038000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Luteinizing Hormone Suppression by Progestin-Primed Ovarian Stimulation Is Associated With Higher Implantation Rate for Patients With Polycystic Ovary Syndrome Who Underwent in vitro Fertilization\/Intracytoplasmic Sperm Injection Cycles: Comparing With Short Protocol"],"prefix":"10.3389","volume":"12","author":[{"given":"Chen","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weina","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiguang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiqiang","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menghui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renfei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuju","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifeng","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/humupd\/dmaa040","article-title":"Progestins for pituitary suppression during ovarian stimulation for ART: a comprehensive and systematic review including meta-analyses.","volume":"27","author":"Ata","year":"2020","journal-title":"Hum. Reprod. Update"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.57","article-title":"Polycystic ovary syndrome.","volume":"2","author":"Azziz","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"B3","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/humupd\/dmw025","article-title":"The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance.","volume":"22","author":"Balen","year":"2016","journal-title":"Hum. Reprod. Update"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1111\/j.1471-0528.1993.tb15170.x","article-title":"Hypersecretion of luteinising hormone: a significant cause of infertility and miscarriage.","volume":"100","author":"Balen","year":"1993","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00639","article-title":"Low LH Level on the Day of GnRH Agonist Trigger Is Associated With Reduced Ongoing Pregnancy and Live Birth Rates and Increased Early Miscarriage Rates Following IVF\/ICSI Treatment and Fresh Embryo Transfer.","volume":"10","author":"Benmachiche","year":"2019","journal-title":"Front. Endocrinol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/j.fertnstert.2005.05.040","article-title":"Serum luteinizing hormone in patients undergoing ovarian stimulation with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone and its relationship with cycle outcome.","volume":"84","author":"Bosch","year":"2005","journal-title":"Fertil. Steril."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1038\/nm.3012","article-title":"Mechanisms of implantation: strategies for successful pregnancy.","volume":"18","author":"Cha","year":"2012","journal-title":"Nat. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/humupd\/dmx040","article-title":"Acquisition of oocyte competence to develop as an embryo: integrated nuclear and cytoplasmic events.","volume":"24","author":"Conti","year":"2018","journal-title":"Hum. Reprod. Update"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/medsci7080084","article-title":"The Role of the Brain in the Pathogenesis and Physiology of Polycystic Ovary Syndrome (PCOS).","volume":"7","author":"Coutinho","year":"2019","journal-title":"Med. Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/BF01133388","article-title":"A formula for scoring human embryo growth rates in in vitro fertilization: its value in predicting pregnancy and in comparison with visual estimates of embryo quality.","volume":"3","author":"Cummins","year":"1986","journal-title":"J. In Vitro Fert. Embryo Transf."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1210\/endo-92-5-1496","article-title":"Blockade by progesterone of estrogen-induced LH and FSH release in the rhesus monkey.","volume":"92","author":"Dierschke","year":"1973","journal-title":"Endocrinology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1111\/1471-0528.14622","article-title":"The pregnancy outcome of progestin-primed ovarian stimulation using 4 versus 10 mg of medroxyprogesterone acetate per day in infertile women undergoing in vitro fertilisation: a randomised controlled trial.","volume":"124","author":"Dong","year":"2017","journal-title":"BJOG"},{"key":"B13","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.rbmo.2009.12.019","article-title":"LH concentrations do not correlate with pregnancy in rFSH\/GnRH antagonist cycles.","volume":"20","author":"Doody","year":"2010","journal-title":"Reprod. Biomed. Online"},{"key":"B14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/OGX.0b013e31815e85fc","article-title":"Polycystic ovary syndrome and oocyte developmental competence.","volume":"63","author":"Dumesic","year":"2008","journal-title":"Obstet. Gynecol. Surv."},{"key":"B15","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1093\/humupd\/dmn015","article-title":"Follicle dynamics and anovulation in polycystic ovary syndrome.","volume":"14","author":"Franks","year":"2008","journal-title":"Hum. Reprod. Update"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/s0015-0282(00)00518-5","article-title":"Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer.","volume":"73","author":"Gardner","year":"2000","journal-title":"Fertil. Steril."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1111\/jog.14267","article-title":"Dydrogesterone-primed ovarian stimulation is an effective alternative to gonadotropin-releasing hormone antagonist protocol for freeze-all cycles in polycystic ovary syndrome.","volume":"46","author":"Gurbuz","year":"2020","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-08805-1","article-title":"Hypothalamic effects of progesterone on regulation of the pulsatile and surge release of luteinising hormone in female rats.","volume":"7","author":"He","year":"2017","journal-title":"Sci. Rep."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7827-1-108","article-title":"Sperm preparation for ART.","volume":"1","author":"Henkel","year":"2003","journal-title":"Reprod. Biol. Endocrinol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1136\/bmj.297.6655.1024","article-title":"Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome.","volume":"297","author":"Homburg","year":"1988","journal-title":"BMJ"},{"key":"B21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/s0303-7207(99)00219-1","article-title":"Role of LH and FSH in ovarian function.","volume":"161","author":"Howles","year":"2000","journal-title":"Mol. Cell Endocrinol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/s0140-6736(86)90395-8","article-title":"Effect of high tonic levels of luteinising hormone on outcome of in-vitro fertilisation.","volume":"2","author":"Howles","year":"1986","journal-title":"Lancet"},{"key":"B23","doi-asserted-by":"publisher","first-page":"4461","DOI":"10.2147\/DDDT.S230129","article-title":"Progestin-Primed Ovarian Stimulation with Dydrogesterone versus Medroxyprogesterone Acetate in Women with Polycystic Ovarian Syndrome for in vitro Fertilization: a Retrospective Cohort Study.","volume":"13","author":"Huang","year":"2019","journal-title":"Drug Des. Devel. Ther."},{"key":"B24","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/s0015-0282(02)04920-8","article-title":"Exposure to high levels of luteinizing hormone and estradiol in the early follicular phase of gonadotropin-releasing hormone antagonist cycles is associated with a reduced chance of pregnancy.","volume":"79","author":"Kolibianakis","year":"2003","journal-title":"Fertil. Steril."},{"key":"B25","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.fertnstert.2015.03.022","article-title":"Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization.","volume":"104","author":"Kuang","year":"2015","journal-title":"Fertil. Steril."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1093\/humrep\/deaa068","article-title":"Comparison of euploidy rates of blastocysts in women treated with progestins or GnRH antagonist to prevent the luteinizing hormone surge during ovarian stimulation.","volume":"35","author":"La Marca","year":"2020","journal-title":"Hum. Reprod."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.640047","article-title":"Low Serum LH Levels During Ovarian Stimulation With GnRH Antagonist Protocol Decrease the Live Birth Rate After Fresh Embryo Transfers but Have No Impact in Freeze-All Cycles.","volume":"12","author":"Luo","year":"2021","journal-title":"Front. Endocrinol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.rbmo.2020.01.016","article-title":"Does LH suppression by progesterone-primed ovarian stimulation compared with GnRH antagonist affect live birth rate among oocyte recipients?.","volume":"40","author":"Martinez","year":"2020","journal-title":"Reprod. Biomed. Online"},{"key":"B29","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/humupd\/dmw047","article-title":"New stimulation regimens: endogenous and exogenous progesterone use to block the LH surge during ovarian stimulation for IVF.","volume":"23","author":"Massin","year":"2017","journal-title":"Hum. Reprod. Update"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yfrne.2017.05.002","article-title":"Polycystic ovary syndrome: understanding the role of the brain.","volume":"46","author":"Moore","year":"2017","journal-title":"Front. Neuroendocrinol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.tem.2016.11.008","article-title":"Oocyte Competence in Women with Polycystic Ovary Syndrome.","volume":"28","author":"Palomba","year":"2017","journal-title":"Trends Endocrinol. Metab."},{"key":"B32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/humupd\/dmq032","article-title":"Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence.","volume":"17","author":"Qiao","year":"2011","journal-title":"Hum. Reprod. Update"},{"key":"B33","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/0140-6736(90)92765-A","article-title":"Hypersecretion of luteinising hormone, infertility, and miscarriage.","volume":"336","author":"Regan","year":"1990","journal-title":"Lancet"},{"key":"B34","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1093\/humupd\/dmq029","article-title":"Predictive value of oocyte morphology in human IVF: a systematic review of the literature.","volume":"17","author":"Rienzi","year":"2011","journal-title":"Hum. Reprod. Update"},{"key":"B35","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).","volume":"19","year":"2004","journal-title":"Hum. Reprod."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1093\/humrep\/13.7.1901","article-title":"The relationship between follicular fluid aspirate volume and oocyte maturity in in-vitro fertilization cycles.","volume":"13","author":"Salha","year":"1998","journal-title":"Hum. Reprod."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/s0015-0282(16)55968-8","article-title":"Luteinizing hormone: its role, mechanism of action, and detrimental effects when hypersecreted during the follicular phase.","volume":"59","author":"Shoham","year":"1993","journal-title":"Fertil. Steril."},{"key":"B38","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1210\/jcem-58-2-378","article-title":"Progesterone modulation of pulsatile luteinizing hormone secretion in normal women.","volume":"58","author":"Soules","year":"1984","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B39","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/j.1471-0528.1985.tb01113.x","article-title":"Reduced in-vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase.","volume":"92","author":"Stanger","year":"1985","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-32128-4","article-title":"Elevated basal luteinizing hormone does not impair the outcome of human menopausal gonadotropin and medroxyprogesterone acetate treatment cycles.","volume":"8","author":"Sun","year":"2018","journal-title":"Sci. Rep."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF02765740","article-title":"The significance of high follicular-phase luteinizing hormone levels in the treatment of women with polycystic ovarian syndrome by in vitro fertilization.","volume":"14","author":"Tarlatzis","year":"1997","journal-title":"J. Assist. Reprod. Genet."},{"key":"B42","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1093\/humrep\/17.12.3129","article-title":"Effects of exogenous LH administration during ovarian stimulation of pituitary down-regulated young oocyte donors on oocyte yield and developmental competence.","volume":"17","author":"Tesarik","year":"2002","journal-title":"Hum. Reprod."},{"key":"B43","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1093\/humrep\/dem426","article-title":"Consensus on infertility treatment related to polycystic ovary syndrome.","volume":"23","year":"2008","journal-title":"Hum. Reprod."},{"key":"B44","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.bpobgyn.2004.06.001","article-title":"The pathogenesis of infertility and early pregnancy loss in polycystic ovary syndrome.","volume":"18","author":"van der Spuy","year":"2004","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002939","article-title":"Controlled Ovarian Stimulation Using Medroxyprogesterone Acetate and hMG in Patients With Polycystic Ovary Syndrome Treated for IVF: a Double-Blind Randomized Crossover Clinical Trial.","volume":"95","author":"Wang","year":"2016","journal-title":"Medicine"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010290.pub3","article-title":"Gonadotrophins for ovulation induction in women with polycystic ovary syndrome.","volume":"1","author":"Weiss","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"B47","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s11596-019-2055-x","article-title":"Flexible GnRH Antagonist Protocol versus Progestin-primed Ovarian Stimulation (PPOS) Protocol in Patients with Polycystic Ovary Syndrome: comparison of Clinical Outcomes and Ovarian Response.","volume":"39","author":"Xiao","year":"2019","journal-title":"Curr. Med. Sci."},{"key":"B48","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00404-012-2568-z","article-title":"Clinical characteristics, metabolic features, and phenotype of Chinese women with polycystic ovary syndrome: a large-scale case-control study.","volume":"287","author":"Zhang","year":"2013","journal-title":"Arch. Gynecol. Obstet."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004193","article-title":"The Utrogestan and hMG protocol in patients with polycystic ovarian syndrome undergoing controlled ovarian hyperstimulation during IVF\/ICSI treatments.","volume":"95","author":"Zhu","year":"2016","journal-title":"Medicine"}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2021.744968\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T09:17:23Z","timestamp":1644571043000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2021.744968\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,11]]},"references-count":49,"alternative-id":["10.3389\/fphys.2021.744968"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2021.744968","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,11]]},"article-number":"744968"}}